To cite this paper use one of the standards below:
INTRODUCTION: Fridericia platyphylla, belonging to the Bignoninaceae family, is an endemic species of the Brazilian Cerrado. Popularly known as "cervejinha-do-campo", this plant has been attributed anti-inflammatory, antibacterial and analgesic activities. Recent studies have identified that Flavonoids stand out in this species, being found in various parts, including the leaves, where they are the majority secondary metabolites. The present study investigated the toxicity of the hydroethanolic extract of Fridericia platyphylla leaves (EHFP) in an animal model. METHODS: The acute toxicity of EHFP was tested in adult female Rattus norvegicus rats, which were periodically monitored for feed consumption, weight development, water intake and excreta production. EHFP 2000 mg/kg was administered orally (gavage) to 5 animals. Another 5 animals received a proportional volume of 0.9% NaCl saline solution. After administration of the extract, the animals were monitored for 6 consecutive hours. Behavioral assessment was carried out daily, as well as analysis of hematological, biochemical and histopathological parameters at the end of 14 days. The study was approved by the Animal Research Ethics Committee under No. 23115.013098/2020-73. RESULTS: The results show that there was no mortality among the animals that received EHFP, suggesting a lethal dose of > 2000 mg/kg. No changes in behavior, water intake or food consumption were observed. There was a slight influence on the diastolic pressure of the animals, when compared to the animals in the group that received saline, but these variations were within the normal range for blood pressure in rats, ruling out a hypertensive effect. The organs showed no significant differences, except for a slight increase in liver weight in the treated groups. CONCLUSION: The study therefore proved that the hydroethanolic extract of the leaves of Fridericia platyphylla was non-toxic at high doses and safe to take orally. The study also contributes to the scientific validation of the species and its potential as a candidate for the treatment of conditions affecting humans.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper